findmyKOL
Clinical trialNCT03712345TerminatedPhase 2Interventional

Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA

SponsorInflaRx GmbHEnrollment20Granulomatosis With Polyangiitis (GPA)Microscopic Polyangiitis (MPA)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of Alberta Hospital

    Edmonton, Alberta, Canada

  • St. Josephs Healthcare

    Hamilton, Ontaria, Canada

  • Mount Sinai Hospital

    Toronto, Ontario, Canada

  • Chum Centre de Recherche

    Québec, Quebec, Canada

  • Centre de Recherche Musculo-Squelettique

    Trois-Rivières, Quebec, Canada

United States
  • Mayo Clinic Scottsdale

    Scottsdale, Arizona, United States

  • Loma Linda University Clinical Trial Center

    Loma Linda, California, United States

  • Science Connections, Llc

    Doral, Florida, United States

  • University of Miami

    Miami, Florida, United States

  • Rush University Medical Center

    Chicago, Illinois, United States

  • University of Kansas Medical Center Research Institute, Inc.

    Kansas City, Kansas, United States

  • Lsu Health Sciences Center Shreveport

    Shreveport, Louisiana, United States

  • Johns Hopkins Bayview Medical Center

    Baltimore, Maryland, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • University of Mi Medcl Ctr-Rhu

    Ann Arbor, Michigan, United States

  • Henry Ford Hospital

    Detroit, Michigan, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Washington University

    St Louis, Missouri, United States

  • University of New Mexico

    Albuquerque, New Mexico, United States

  • Northwell Health, Llc Prime

    New Hyde Park, New York, United States

  • Hospital for Special Surgery

    New York, New York, United States

  • University of Rochester Medical Center - Strong Memorial Hospital

    Rochester, New York, United States

  • Unc Kidney Center, Unc-Ch Division of Nephrology and Hypertension

    Chapel Hill, North Carolina, United States

  • Trinity Medical Group

    Minot, North Dakota, United States

  • Ohio State University Clinical Trials Management Office

    Columbus, Ohio, United States

  • Oregon Health & Science University

    Portland, Oregon, United States

  • Brcr Medical Center, Inc.

    Camp Hill, Pennsylvania, United States

  • Altoona Center for Clinical Research, P.C.

    Duncansville, Pennsylvania, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Rhode Island Hospital

    Providence, Rhode Island, United States

  • Low Country Rheumatology, Pa

    North Charleston, South Carolina, United States

  • Adriana Pop Moody Clinic Pa

    Corpus Christi, Texas, United States

  • Texas Health Resources

    Dallas, Texas, United States

  • Texas Research Institute

    Fort Worth, Texas, United States

  • Pioneer Research Solutions, Inc.

    Houston, Texas, United States

  • Uva University Physicians Charlottesville

    Charlottesville, Virginia, United States

  • West Virginia University

    Morgantown, West Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Oct 2018
Primary completion
10 Sept 2020
Completion
3 May 2021
Last update posted
26 May 2022
Registered enrollment
20
Registry id
NCT03712345

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.